To address the impact of manipulating UGDH levels on enzyme expression and metabolic outputs, we used an isogenic cell culture model of androgen dependent (AD) and CR prostate cancer, LNCaP 33 and 81, respectively, as previously described [17, 18]. The gene discussed is UGDH; the disease is prostate carcinoma.